Polymun Scientific, founded in 1992, is a private CDMO specializing in recombinant proteins. Polymun focuses on contract development and manufacturing of biopharmaceuticals using mammalian cell technology as well as utilizing innovative technology for the development and manufacture of liposomal formulations. Based near Vienna, the company also has their own proprietary product pipeline with R&D projects and technologies open for co-development and licensing. Polymun operates in accordance with current GMP guidelines and holds an Austrian production license for pharmaceuticals, meeting the European Union requirements for drug manufacturing.